Metagenomi, Inc. Common Stock ( MGX) - Stock Earnings
MGX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 10, 2026, midnight | — / — | — | — / — | — |
MGX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -22.5 million USD | 3.9 million USD |
| 2026Q1 | -23.1 million USD | 1.2 million USD |
| 2026Q2 | -27.5 million USD | -257000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MGX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -68.3 million USD | 44.8 million USD |
| 2024 | -78.1 million USD | 52.3 million USD |
| 2025 | -87.9 million USD | 25.2 million USD |
| 2026 Est. | — | — |
MGX
Price: $0.81
52 week price:
Earnings Per Share: -2.45 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 38.8 million